The U.S. Food and Drug Administration's (FDA) Drugs Advisory Committee is recommending stronger warning labels for the pain reliever acetaminophen. Mainly sold in the United States under the brand name Tylenol, acetaminophen has been a concern for health regulators for years due to its link to liver toxicity. But recently, reports of overdose, the most common cause of acetaminophen-associated liver toxicity, have been increasing.

According to the FDA, 13,000 emergency room visits and 100 deaths a year are attributed to acetaminophen overuse. The advisory committee suggests a new label on all brands of the painkiller informing consumers about the effects of an overdose. The addition of a bolded warning is also being considered.